The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Fluid retention 28
SANDOSTATIN LAR DEPOT Hepatic neoplasm 28
SANDOSTATIN LAR DEPOT Inflammation 28
SANDOSTATIN LAR DEPOT Lethargy 28
SANDOSTATIN LAR DEPOT Limb discomfort 28
SANDOSTATIN LAR DEPOT Neoplasm 28
SANDOSTATIN LAR DEPOT Therapeutic response decreased 28
SANDOSTATIN Needle issue 27
SANDOSTATIN LAR DEPOT Crying 27
SANDOSTATIN LAR DEPOT Depressed mood 27
SANDOSTATIN LAR DEPOT Eating disorder 27
SANDOSTATIN LAR DEPOT Eye pain 27
SANDOSTATIN LAR DEPOT Heart rate irregular 27
SANDOSTATIN LAR DEPOT Loss of consciousness 27
SANDOSTATIN LAR DEPOT Lung disorder 27
SANDOSTATIN LAR DEPOT Musculoskeletal stiffness 27
SANDOSTATIN LAR DEPOT Respiratory rate increased 27
SANDOSTATIN LAR DEPOT Vision blurred 27
SANDOSTATIN LAR DEPOT Bone pain 26
SANDOSTATIN LAR DEPOT Oedema 26

Total Records: 2,045     Number of Pages: 103